Citation Impact
Citing Papers
Anti-S1P Antibody as a Novel Therapeutic Strategy for VEGFR TKI-Resistant Renal Cancer
2015
Graft microvascular disease in solid organ transplantation
2014 StandoutNobel
ATF6 Mediates a Pro-Inflammatory Synergy Between ER Stress and TLR Activation in the Pathogenesis of Liver Ischemia-Reperfusion Injury
2014
Role of ABCC1 in export of sphingosine-1-phosphate from mast cells
2006
Transition from inflammation to proliferation: a critical step during wound healing
2016 Standout
Hypoxia-Inducible Factors and the Response to Hypoxic Stress
2010 Standout
Interleukin-1 Regulates the Expression of Sphingosine Kinase 1 in Glioblastoma Cells
2008
Sphingosine Kinase 1 in Cancer
2013
Mechanisms, regulation and functions of the unfolded protein response
2020 Standout
A comparison of epithelial-to-mesenchymal transition and re-epithelialization
2012
Normalization of diabetic wound healing
2009
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
2010 Standout
Cancer to bone: a fatal attraction
2011 Standout
The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy
2015 Standout
Contribution of platelets to tumour metastasis
2011 Standout
A comprehensive map of molecular drug targets
2016 Standout
Finding a way out: lymphocyte egress from lymphoid organs
2007
ROS in cancer therapy: the bright side of the moon
2020 Standout
Sphingolipid metabolism in cancer signalling and therapy
2017
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
2012 Standout
Ceramides and other bioactive sphingolipid backbones in health and disease: Lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy
2006
Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond
2013
Sphingolipids and their metabolism in physiology and disease
2017 Standout
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
2014 StandoutNature
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
Lymphangiogenesis: Molecular Mechanisms and Future Promise
2010 Standout
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Fumonisin B1 and the kidney: Modes of action for renal tumor formation by fumonisin B1 in rodents
2012
Principles of bioactive lipid signalling: lessons from sphingolipids
2008 Standout
Mammalian ceramide synthases
2010 Standout
In vivo toxicity studies of fusarium mycotoxins in the last decade: A review
2015 Standout
The Human Plasma Lipidome
2011
A lifetime of stress: ATF6 in development and homeostasis
2018
STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors
2010
Sphingosine-1-phosphate lyase in immunity and cancer: silencing the siren
2007
Lipid signalling in disease
2008
Emerging Biological Principles of Metastasis
2017 Standout
Cellular Fatty Acid Metabolism and Cancer
2013 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
EMT: 2016
2016 Standout
Membrane lipids: where they are and how they behave
2008 Standout
Activation of apoptosis signalling pathways by reactive oxygen species
2016 Standout
S1PR1-STAT3 Signaling Is Crucial for Myeloid Cell Colonization at Future Metastatic Sites
2012
Hallmarks of Cellular Senescence
2018 Standout
Lysophospholipid receptors: Signalling, pharmacology and regulation by lysophospholipid metabolism
2006
ABC transporters in cancer: more than just drug efflux pumps
2010
The PtdIns(3,4)P2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death
2010 StandoutNatureNobel
Dysregulated pH: a perfect storm for cancer progression
2011 Standout
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
The Pathobiology of Vascular Dementia
2013 Standout
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Sphingosine‐1‐phosphate signaling in physiology and diseases
2012
Exploring the full spectrum of macrophage activation
2008 Standout
Roles of Bioactive Sphingolipids in Cancer Biology and Therapeutics
2008
Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
2012 StandoutNobel
ER stress-induced cell death mechanisms
2013 Standout
Blockade of sphingosine‐1‐phosphate reduces macrophage influx and retinal and choroidal neovascularization
2008
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
2016 Standout
Second generation S1P pathway modulators: Research strategies and clinical developments
2013
LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling
2013 StandoutNature
Sphingosine 1-Phosphate Enhances Fcγ Receptor-Mediated Neutrophil Activation and Recruitment under Flow Conditions
2009
Sphingosine 1-phosphate signaling is involved in skeletal muscle regeneration
2009
Age-Associated mRNA and miRNA Expression Changes in the Blood-Brain Barrier
2019 StandoutNobel
Sphingosine-1-phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is down-regulated in colon cancer
2006
Exosomes
2019 Standout
S1PR1 is an effective target to block STAT3 signaling in activated B cell–like diffuse large B-cell lymphoma
2012
Interplay Between the Oxidoreductase PDIA6 and microRNA-322 Controls the Response to Disrupted Endoplasmic Reticulum Calcium Homeostasis
2014
Tumor Cell Apoptosis Polarizes Macrophages—Role of Sphingosine-1-Phosphate
2007
Digoxin inhibits retinal ischemia‐induced HIF‐1α expression and ocular neovascularization
2010 StandoutNobel
Intracellular sphingosine kinase 2‐derived sphingosine‐1‐phosphate mediates epidermal growth factor‐induced ezrin‐radixin‐moesin phosphorylation and cancer cell invasion
2015
Intestinal permeability – a new target for disease prevention and therapy
2014 Standout
Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Cardiovascular Epidemiology and Genetics
2015 Standout
Epithelial cell extrusion requires the sphingosine-1-phosphate receptor 2 pathway
2011
Communication in the Cancer Microenvironment as a Target for Therapeutic Interventions
2020
The Biological Basis for Cardiac Repair After Myocardial Infarction
2016 Standout
Natural product and natural product derived drugs in clinical trials
2014 Standout
Sphingolipids and Cancer: Ceramide and Sphingosine-1-Phosphate in the Regulation of Cell Death and Drug Resistance
2010
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
Cardiomyocyte-Specific Transforming Growth Factor β Suppression Blocks Neutrophil Infiltration, Augments Multiple Cytoprotective Cascades, and Reduces Early Mortality After Myocardial Infarction
2014
The supernatant of apoptotic cells causes transcriptional activation of hypoxia-inducible factor–1α in macrophages via sphingosine-1-phosphate and transforming growth factor-β
2009
Satellite Cells and the Muscle Stem Cell Niche
2013 Standout
G-protein-coupled receptors and cancer
2007
Role of sphingosine kinase‐1 in paracrine/transcellular angiogenesis and lymphangiogenesis in vitro
2010
Sphingosine-1-phosphate promotes lymphangiogenesis by stimulating S1P1/Gi/PLC/Ca2+ signaling pathways
2008
Works of John Vekich being referenced
Mesencephalic Astrocyte-derived Neurotrophic Factor Protects the Heart from Ischemic Damage and Is Selectively Secreted upon Sarco/endoplasmic Reticulum Calcium Depletion
2012
Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages
2006
Production and characterization of monoclonal anti-sphingosine-1-phosphate antibodies
2009
Protein disulfide isomerase-associated 6 is an ATF6-inducible ER stress response protein that protects cardiac myocytes from ischemia/reperfusion-mediated cell death
2012